EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Promise of RNA Interference as a Pharmaceutical Tool

Dr. Maria J. Smith

American Journal of Pharmaceutics · 31.10.2022 · 3 (5) · 1-12

DOI: 10.71465/ajph2174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Pharmaceutics, online erschienen am 31.10.2022. Verfasst von Dr. Maria J. Smith. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA interference (RNAi) is a natural cellular process that regulates gene expression by silencing specific messenger RNAs (mRNAs), thereby preventing the translation of genes into proteins. RNAi has emerged as a promising tool for pharmaceutical applications, enabling the targeted suppression of disease-related genes, including those involved in cancer, viral infections, genetic disorders, and autoimmune diseases. This article explores the potential of RNAi as a therapeutic approach, highlighting its mechanisms, challenges, and progress in clinical applications. Despite the therapeutic promise, several hurdles such as efficient delivery systems, off-target effects, and long-term safety remain. The future of RNAi-based therapeutics will likely depend on overcoming these challenges and optimizing RNAi delivery techniques.

Zitieren

APA

Smith, D. M. J. (2022). The Promise of RNA Interference as a Pharmaceutical Tool. American Journal of Pharmaceutics, 3(5), 1-12. https://doi.org/10.71465/ajph2174

Vancouver

Smith DMJ. The Promise of RNA Interference as a Pharmaceutical Tool. American Journal of Pharmaceutics. 2022;3(5):1-12. doi:10.71465/ajph2174

BibTeX
@article{Smith2022,
  author = {Smith, Dr. Maria J.},
  title = {The Promise of RNA Interference as a Pharmaceutical Tool},
  journal = {American Journal of Pharmaceutics},
  year = {2022},
  volume = {3},
  number = {5},
  pages = {1--12},
  doi = {10.71465/ajph2174}
}
Kostenlos starten →